Evidence Builds for Scalp Cooling

Growing evidence suggests that scalp cooling can alleviate chemotherapy-induced hair loss. The most recent data ...

JUNE 19, 2017

Studies Shed Light on Pregnancy-Associated Breast Ca

San Antonio—Pregnancy-associated breast cancer (PABC) has been associated with worse prognosis, but the ...

MAY 15, 2017

Abemaciclib Active in Early Breast Cancer

Results from a Phase II trial support further study of the CDK 4/6 inhibitor abemaciclib and anastrozole in ...

MARCH 17, 2017

Mutational Variability Reveals Therapeutic Potential

San Antonio—Mutations found in a patient’s primary breast cancer and metastatic sites can be different ...

FEBRUARY 1, 2017

Scalp-Cooling Device Prevents Chemo-Related Hair Loss

San Antonio—The first randomized controlled trial testing a scalp-cooling device has demonstrated that it can ...

JANUARY 26, 2017

Buparlisib Improves PFS, But Toxicity Is Concerning

San Antonio—The combination of the PI3K inhibitor buparlisib and endocrine therapy with fulvestrant improved ...

JANUARY 26, 2017

‘Watson for Oncology’ Shows Concordance With Oncologists’ Recommendations

San Antonio—A new artificial intelligence platform, “Watson for Oncology” (WFO), promises to ...

DECEMBER 20, 2016

SABCS 2016: Menopausal Symptoms Affect Adherence To Tamoxifen, And To Placebo

San Antonio—Although menopausal symptoms play a role in adherence to tamoxifen, the strength of the ...

DECEMBER 16, 2016

SABCS 2016: No Improvement in Postmenopausal Breast Ca Patients Treated With Ibandronate Plus Hormone Therapy

Treatment with the bisphosphonate ibandronate in addition to adjuvant hormone therapy did not lead to a ...

DECEMBER 14, 2016

Better Prognostic Tools Are Needed for DCIS

In recent years, controversy has swirled around the treatment of ductal carcinoma in situ (DCIS). At the 2015 San ...

APRIL 11, 2016